Researchers ID Molecular Subtypes of Gastric Cancer Predictive of Survival and Drug Response
August 03, 2011
Researchers ID Molecular Subtypes of Gastric Cancer Predictive of Survival and Drug Response
In a step toward personalizing treatments for gastric cancer, a recently published study showed that molecularly defined disease subtypes respond differently to therapies.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- GenomeWeb Feature: The Rise of Lung Cancer Genetic Testing
May 8, 2013 / Pharmacogenomics Reporter - Prostate Cancer Risk Markers Show Promise for Test to ID Elevated Risk in Men with Benign Hyperplasia
April 3, 2013 / Pharmacogenomics Reporter - MDxHealth and Ghent University Begin Collaboration under New Pharmacoepigenomics Center
December 12, 2012 / Pharmacogenomics Reporter - Study Shows Aspirin Could Increase Survival in Colorectal Cancer Patients with PIK3CA Mutations
November 28, 2012 / Pharmacogenomics Reporter - Prospective Study Suggests Site-Specific Treatment after BioTheranostics' CUP Testing Improves Survival
October 17, 2012 / Pharmacogenomics Reporter